APA

Arnall J. R., Moore D. C., Hill H. L., Griffin S., Mueller M. K., Lavery L. A., Voorhees P. M. & Usmani S. Z. (20200821). Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses. : Leukemia & lymphoma.

Chicago

Arnall Justin R, Moore Donald C, Hill Hailey L, Griffin Sarah, Mueller Maxine K, Lavery Lesli A, Voorhees Peter M and Usmani Saad Z. 20200821. Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses. : Leukemia & lymphoma.

Harvard

Arnall J. R., Moore D. C., Hill H. L., Griffin S., Mueller M. K., Lavery L. A., Voorhees P. M. and Usmani S. Z. (20200821). Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses. : Leukemia & lymphoma.

MLA

Arnall Justin R, Moore Donald C, Hill Hailey L, Griffin Sarah, Mueller Maxine K, Lavery Lesli A, Voorhees Peter M and Usmani Saad Z. Enhancing the feasibility of outpatient daratumumab administration via a split-dosing strategy with initial doses. : Leukemia & lymphoma. 20200821.